                               SEQUENCE LISTING

<110> SIRNAOMICS, INC.
 
<120> TUMOR-TARGETING POLYPEPTIDE NANOPARTICLE DELIVERY SYSTEM FOR 
      NUCLEIC ACID THERAPEUTICS

<130> 4690.0026I

<140> PCT/US2020/054251
<141> 2020-10-05

<150> 62/915,450
<151> 2019-10-15

<150> 62/910,760
<151> 2019-10-04

<160> 18    

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Lys His His His Lys His His His Lys His His His Lys His His His 
1               5                   10                  15      


Lys Cys Ser Ser Cys 
            20      


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Ala Pro Arg Pro Gly 
1               5   


<210> 3
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Cys Gly Lys Arg Lys 
1               5   


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
His Ala Ile Tyr Pro Arg His 
1               5           


<210> 5
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gly Pro Leu Gly Ile Ala Gly Gln 
1               5               


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Val His Leu Gly Tyr Ala Thr 
1               5           


<210> 7
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Tyr Thr Arg Asp Leu Val Lys Asp Pro Ala Arg Pro Lys Ile Gln Lys 
1               5                   10                  15      


Thr Cys Thr Phe 
            20  


<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (6)..(7)
<223> D-amino acid

<400> 8
Gln His Thr Ser Tyr Lys Cys Leu Arg Pro 
1               5                   10  


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Cys Gly Gly Asn His Trp Ala Val Gly His Leu Met 
1               5                   10          


<210> 10
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Tyr Thr Trp Met Pro Glu Asn Pro Arg Pro Gly Thr Pro Cys Asp Ile 
1               5                   10                  15      


Phe Thr Asn Ser Arg Gly Lys Arg Ala Ser Asn Gly 
            20                  25              


<210> 11
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Lys His His His Lys His His His Lys His His His Lys His His His 
1               5                   10                  15      


Lys Ser Ser Ser Cys 
            20      


<210> 12
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Lys His His His Lys His His His Lys His His His Lys His His His 
1               5                   10                  15      


Lys Cys Ser Ser Cys 
            20      


<210> 13
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Lys His His His Lys His His His Lys His His His Lys His His His 
1               5                   10                  15      


Lys Ser Ser Cys 
            20  


<210> 14
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Lys His His His Lys His His His Lys His His His Lys His His His 
1               5                   10                  15      


Lys 
    


<210> 15
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (9)..(9)
<223> May or may not be present

<400> 15
Lys His His His Lys His His His His Lys His His His Lys His His 
1               5                   10                  15      


His Lys Cys 
            


<210> 16
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (9)..(9)
<223> May or may not be present

<400> 16
Lys His His His Lys His His His His Lys His His His Lys His His 
1               5                   10                  15      


His Lys Cys 
            


<210> 17
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Cys or Ser

<400> 17
Lys His His His Lys His His His Lys His His His Lys His His His 
1               5                   10                  15      


Lys Xaa Ser Ser 
            20  


<210> 18
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Lys His His His Lys His His His His Lys His His His Lys His His 
1               5                   10                  15      


His Lys 
        


